ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 58573 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 58573; 2) Community: the network communities that were significantly associated with the response to NSC 58573; 3) Molecule: the relationships between components within communities and NSC 58573; 4) MDR: the compounds that were significantly associated with the NSC 58573.

NSC Compound Enrichment Correlation
NSC 92504 Null 0.024108502230778 0.40722744
NSC 12097 Resorufine 0.0241085022307781 0.23975338
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0241085022307781 0.085794643
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0241085022307781 0.23173074
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0241085022307781 0.20412493
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.0241085022307781 0.2903377
NSC 285233 Null 0.0241085022307781 0.50567962
NSC 295501 Camptothecin Derivative 0.0241085022307781 0.13253451
NSC 319440 Null 0.0241085022307781 -0.3028559
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0241085022307781 0.47195781
Total:125  Current:72    [First] [Prev] [Next] [Last]